Comment on "Posterior reversible encephalopathy syndrome in a patient with metastatic breast cancer : A case report"
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved..
Posterior reversible encephalopathy syndrome (PRES) is a neurotoxic encephalopathic state, manifesting clinical symptoms of headache, altered consciousness, visual disturbances, and seizures. Although several diseases have been identified as causative of PRES, the underlying mechanism remains unclear. Song et al recently published "Posterior reversible encephalopathy syndrome (PRES) in a patient with metastatic breast cancer: A case report" in the World Journal of Clinical Cases, highlighting and discussing the role of hypercalcemia in PRES as related to uncontrolled hypertension. To build upon this case description, we provide further insight into the possible underlying mechanisms of PRES through this commentary.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
World journal of clinical cases - 10(2022), 24 vom: 26. Aug., Seite 8805-8807 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kunić, Suljo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Case report |
|---|
| Anmerkungen: |
Date Revised 28.09.2022 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.12998/wjcc.v10.i24.8805 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM346740649 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM346740649 | ||
| 003 | DE-627 | ||
| 005 | 20231226032156.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.12998/wjcc.v10.i24.8805 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1155.xml |
| 035 | |a (DE-627)NLM346740649 | ||
| 035 | |a (NLM)36157809 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kunić, Suljo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comment on "Posterior reversible encephalopathy syndrome in a patient with metastatic breast cancer |b A case report" |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 28.09.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. | ||
| 520 | |a Posterior reversible encephalopathy syndrome (PRES) is a neurotoxic encephalopathic state, manifesting clinical symptoms of headache, altered consciousness, visual disturbances, and seizures. Although several diseases have been identified as causative of PRES, the underlying mechanism remains unclear. Song et al recently published "Posterior reversible encephalopathy syndrome (PRES) in a patient with metastatic breast cancer: A case report" in the World Journal of Clinical Cases, highlighting and discussing the role of hypercalcemia in PRES as related to uncontrolled hypertension. To build upon this case description, we provide further insight into the possible underlying mechanisms of PRES through this commentary | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Case report | |
| 650 | 4 | |a Hypercalcemia | |
| 650 | 4 | |a Paraneoplastic syndrome | |
| 650 | 4 | |a Posterior reversible encephalopathy syndrome | |
| 700 | 1 | |a Ibrahimagić, Omer Ć |e verfasserin |4 aut | |
| 700 | 1 | |a Kojić, Biljana |e verfasserin |4 aut | |
| 700 | 1 | |a Džananović, Dževad |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t World journal of clinical cases |d 2013 |g 10(2022), 24 vom: 26. Aug., Seite 8805-8807 |w (DE-627)NLM233331727 |x 2307-8960 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2022 |g number:24 |g day:26 |g month:08 |g pages:8805-8807 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.12998/wjcc.v10.i24.8805 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2022 |e 24 |b 26 |c 08 |h 8805-8807 | ||